Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Frazier Life Sciences Public Fund, L.P. reported a 4.80% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13D/A)

Event Aug 18, 2025 · Filed Aug 20, 2025

Frazier Life Sciences Public Fund, L.P. reported a 4.80% stake in Kalvista Pharmaceuticals, Inc., 2,400,276 shares, with active intent on Aug 18, 2025. Filed Aug 20, 2025 (Schedule 13D/A).

Stake
4.80%
Shares
2,400,276
Intent
Active
What changed
Stake changed
Filed together
17 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.4.80%2,400,276
FHMLSP, L.P.4.80%2,400,276
FHMLSP, L.L.C.4.80%2,400,276
Frazier Life Sciences Public Overage Fund, L.P.1.90%946,074
FHMLSP Overage, L.P.1.90%946,074
FHMLSP Overage, L.L.C.1.90%946,074
Frazier Life Sciences X, L.P.2.30%1,156,869
FHMLS X, L.P.2.30%1,156,869
FHMLS X, L.L.C.2.30%1,156,869
Frazier Life Sciences XI, L.P.0.80%384,648
FHMLS XI, L.P.0.80%384,648
FHMLS XI, L.L.C.0.80%384,648
James N. Topper2.30%1,156,869
Patrick J. Heron2.30%1,156,869
Albert Cha0%0
James Brush0%0
Daniel Estes0%0

Source

View original at SEC

Related